ATE400586T1 - Rezeptoren für das humane interleukin-12 - Google Patents

Rezeptoren für das humane interleukin-12

Info

Publication number
ATE400586T1
ATE400586T1 AT01127361T AT01127361T ATE400586T1 AT E400586 T1 ATE400586 T1 AT E400586T1 AT 01127361 T AT01127361 T AT 01127361T AT 01127361 T AT01127361 T AT 01127361T AT E400586 T1 ATE400586 T1 AT E400586T1
Authority
AT
Austria
Prior art keywords
receptor
receptors
binding
complex
human interleukin
Prior art date
Application number
AT01127361T
Other languages
English (en)
Inventor
Ulrich Andreas Gubler
David Howard Presky
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE400586T1 publication Critical patent/ATE400586T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT01127361T 1995-08-01 1996-07-23 Rezeptoren für das humane interleukin-12 ATE400586T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US170195P 1995-08-01 1995-08-01
US1867496P 1996-05-30 1996-05-30

Publications (1)

Publication Number Publication Date
ATE400586T1 true ATE400586T1 (de) 2008-07-15

Family

ID=26669384

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01127361T ATE400586T1 (de) 1995-08-01 1996-07-23 Rezeptoren für das humane interleukin-12
AT96111807T ATE314468T1 (de) 1995-08-01 1996-07-23 Interleukin-12-beta-rezeptoren mit niedriger bindungsaffinität

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT96111807T ATE314468T1 (de) 1995-08-01 1996-07-23 Interleukin-12-beta-rezeptoren mit niedriger bindungsaffinität

Country Status (8)

Country Link
US (3) US5840530A (de)
EP (3) EP1243597B1 (de)
JP (1) JP2948150B2 (de)
AT (2) ATE400586T1 (de)
DE (2) DE69635639T2 (de)
DK (2) DK1243597T3 (de)
ES (2) ES2305024T3 (de)
PT (1) PT1243597E (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6046012A (en) * 1993-07-19 2000-04-04 Hoffmann-La Roche Inc. Antibody to IL-12 receptor
US6830751B1 (en) 1994-03-14 2004-12-14 Genetics Institute, Llc Use of IL-12 antagonists in the treatment of rheumatoid arthritis
PT936923E (pt) * 1996-11-15 2004-04-30 Kennedy Inst Of Rheumatology Supressao de tnfalfa e il-12 em terapia
WO1999025737A1 (en) * 1997-11-19 1999-05-27 Tanox Pharma B.V. Compositions and methods for treatment of autoimmune diseases, using a monoclonal antibody to the interleukin-12 beta2-chain
ATE272114T1 (de) 1998-01-23 2004-08-15 Immunex Corp Rezeptoren für il-18
US6800460B1 (en) 1999-03-11 2004-10-05 Schering Corporation Mammalian cytokine complexes
DE60041393D1 (de) * 1999-03-11 2009-03-05 Schering Corp Cytokine aus säugetieren, verwandte reagenzien und verfahren
AU767068B2 (en) * 1999-06-11 2003-10-30 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of leptin activity
US20020199218A1 (en) * 1999-08-19 2002-12-26 Daphne Goring Proline-rich extensin-like receptor kinases
US6346247B1 (en) 1999-10-28 2002-02-12 Promega Corporation Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies
EP1349937A2 (de) * 2000-10-11 2003-10-08 Biotechnology Research And Development Corporation Klonierung und sequenzierung der beta-1 und beta-2 ketten vom interleukin-12 rezeptor aus schwein
CA2364983A1 (en) * 2000-12-13 2002-06-13 John R. Coleman Nucleic acid molecules and polypeptides for catabolism of abscisic acid
NZ570709A (en) 2003-06-13 2010-04-30 Univ Pennsylvania Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
US20070178520A1 (en) * 2004-02-27 2007-08-02 Barbara Wolff-Winiski Screening assay for modulators of interaction between interleukin-12 and/or -23 with their receptors
AU2007298571B2 (en) 2006-09-22 2012-06-07 St. Jude Children's Research Hospital Modulating regulatory T cell activity via Interleukin 35
US20130183326A9 (en) * 2009-11-20 2013-07-18 St. Jude Children's Research Hospital Methods and compositions for modulating the activity of the interleukin-35 receptor complex
CN118922196A (zh) * 2022-02-18 2024-11-08 加利福尼亚大学董事会 嵌合细胞因子受体促进原代人nk细胞扩增和功能

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536657A (en) * 1993-07-19 1996-07-16 Hoffmann-La Roche Inc. Recombinant DNA encoding human receptor for interleukin-12
EP0638644A1 (de) 1993-07-19 1995-02-15 F. Hoffmann-La Roche Ag Interleukin-12 Rezeptoren und Antikörper

Also Published As

Publication number Publication date
DK1243597T3 (da) 2008-09-22
ES2255067T3 (es) 2006-06-16
DE69635639D1 (de) 2006-02-02
EP1950226A3 (de) 2010-08-11
EP0759466A2 (de) 1997-02-26
DK0759466T3 (da) 2006-05-15
US5840530A (en) 1998-11-24
EP1243597B1 (de) 2008-07-09
JP2948150B2 (ja) 1999-09-13
EP1243597A3 (de) 2004-05-06
JPH09132598A (ja) 1997-05-20
ATE314468T1 (de) 2006-01-15
PT1243597E (pt) 2008-10-17
DE69635639T2 (de) 2006-09-14
DE69637599D1 (de) 2008-08-21
EP1243597A2 (de) 2002-09-25
ES2305024T3 (es) 2008-11-01
US5852176A (en) 1998-12-22
EP0759466A3 (de) 1997-05-28
EP0759466B1 (de) 2005-12-28
US5919903A (en) 1999-07-06
EP1950226A2 (de) 2008-07-30

Similar Documents

Publication Publication Date Title
DE69637599D1 (de) Rezeptoren für das humane Interleukin-12
DK1798288T3 (da) Humane Toll-lignende receptorproteiner, relaterede reagenser og fremgangsmåder
ATE353965T1 (de) An g-protein gekoppelte rezeptoren und deren verwendungen
NZ512083A (en) Methods of increasing lean tissue mass using OB protein compositions
EP2264152A3 (de) Fusionskonstrukte und deren verwendung zur produktion von antikörpern mit erhöhter fc rezeptor bindungsaffinität und effektorfunktion
DE60140218D1 (de) Expressionsvektor für tierische zellen
EA200600525A1 (ru) Еро-имитирующие миметичекие антитела человека с центральной шарнирной областью, композиции, способы и применения
AU2894289A (en) Domain-modified constant region antibodies
DE69233191D1 (de) Cyclin d1 und seine cdna
ATE136906T1 (de) Antikörperantagonisten gegen humanes interleukin- 4
ATE387458T1 (de) Fas-antigenbindender ligand
ATE295423T1 (de) Phosphodiesterase 8
WO1998011221A3 (en) CAR, a novel coxsackievirus and adenovirus receptor
NO971059D0 (no) Modifiserte human-C3-proteiner
DE68925275D1 (de) Endotoxin-bindeprotein und dessen verwendung
WO1999033870A3 (en) Human regulatory proteins
WO1999024835A3 (en) An immunoassay for procollagen-iii-c-terminal propeptide
DK0868511T3 (da) Genekspression af utrophin
EP2301947A3 (de) Sekretierte Proteine und Verwendungen dafür
DE60142356D1 (de) 18480 humane proteinkinasemoleküle und ihre verwendungen
DE50015355D1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
ZA91699B (en) Antibodies specifically recognizing somatotropin binding protein
WO1999058641A8 (en) Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors
WO1998050425A3 (en) Human tsc-22-like proteins
WO2001066745A3 (en) Presenilin/crk binding polypeptides (pcbp) and methods of use thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1243597

Country of ref document: EP